Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone: Update of the Phase 3 MAIA Trial - Perrot, Aurore; Facon, Thierry; Kumar, Shaji; Plesner, Torben; Orlowski, Robert Z.; Moreau, Philippe; Bahlis, Nizar J.; Basu, Supratik; Nahi, Hareth; Hulin, Cyrille; Quach, Hang; Goldschmidt, Hartmut; et al. (Blood, 2021)